Advances in Hematological Malignancies
Recent years have witnessed remarkable strides in the domain of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and therapy are revolutionizing the prognosis for patients with blood cancers. Clinical trials continue to explore these innovative techniques, offering promise for more effective treatment options.